Tuesday 1st November 2022 |
Text too small? |
Offer : A pro rata renounceable rights issue of 1 New Share for every 10 Existing Shares held at 5.00pm (NZ time) on the Record Date, with fractional entitlements being rounded down to the nearest share.
Eligible Shareholders : A Shareholder with a registered address in
• New Zealand at 5.00pm (NZ time) on the Record Date.
• Australia at 5.00pm (NZ time) on the Record Date, provided that the shareholder is a Wholesale Shareholder.
Rights : The right to subscribe for New Shares under the Offer. Eligible Shareholders have an entitlement to subscribe for 1 New Share for every 10 Existing Shares held on the Record Date (5.00pm, 2 November 2022). Eligible Shareholders may take up some or all or none of their Rights
Application Price : NZ$0.85 per New Share, which sum is payable by shareholders with a registered address in New Zealand, or AUD $0.77 per New Share which sum is payable by Wholesale Shareholders with a registered address in Australia.
The Application price represented a 20.62% discount to the 30-day VWAP for the Company’s shares as at the date of the announcement of this Offer to the market.
Offer size : Approximate amount to be raised under the Offer: NZD $1,373,405
New Shares : Ordinary Shares of the same class as, and that rank equally with, Existing Shares at the time of allotment of the New Shares.
Shares currently on issue : 16,157,699 Ordinary Shares quoted on the Main Board
Maximum number of New Shares being offered : Up to 1,615,770 New Shares.
Maximum number of Ordinary Shares on completion of the Offer :
17,773,469 Ordinary Shares
How to apply : Applications must be made by either completing an online application at https://enprise.rightsoffer.co.nz. Payment may be made in New Zealand dollars or Australian dollars.
Underwriting : The Offer is not underwritten.
2022 Rights Issue Offer Document
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b